Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 26, 2012 08:00 ET | Source: Novavax, Inc.

NOVAVAX to Report First Quarter 2012 Financial Results on May 4, 2012

ROCKVILLE, Md., April 26, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that it will report its 2012 first-quarter financial results on Friday, May 4, 2012, before the U.S....
April 03, 2012 08:00 ET | Source: Novavax, Inc.

NOVAVAX to Present at the 11th Annual Needham Healthcare Conference

ROCKVILLE, Md., April 3, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) a clinical-stage vaccine company, announced today that Frederick W. Driscoll, Vice President and Chief Financial Officer...
March 22, 2012 09:52 ET | Source: Novavax, Inc.

NOVAVAX to Present Results From Phase I RSV Study at XIV International Symposium on Respiratory Viral Infections

ROCKVILLE, Md., March 22, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today that Louis F. Fries III, M.D., its Vice President, Clinical and Medical Affairs, will present results...
March 12, 2012 10:00 ET | Source: Novavax, Inc.

NOVAVAX to Present at the 24th Annual ROTH Conference

ROCKVILLE, Md., March 12, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company, announced today that Stanley C. Erck, President and Chief Executive Officer of...
March 09, 2012 08:00 ET | Source: Novavax, Inc.

NOVAVAX Reports Fourth Quarter and 2011 Year-End Financial Results

ROCKVILLE, Md., March 9, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced financial results for the fourth quarter and year ended December 31, 2011. For the fourth quarter of...
March 08, 2012 09:00 ET | Source: Novavax, Inc.

NOVAVAX Appoints John A. Herrmann III, Vice President and General Counsel

ROCKVILLE, Md., March 8, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today the appointment of Mr. John A. Herrmann III to the position of Vice President and General Counsel. Mr....
March 01, 2012 16:30 ET | Source: Novavax, Inc.

NOVAVAX Launches Phase II Clinical Trial of Seasonal Influenza Vaccine

ROCKVILLE, Md., March 1, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that it has begun enrollment in a Phase II clinical trial of its quadrivalent seasonal influenza...
February 24, 2012 08:00 ET | Source: Novavax, Inc.

NOVAVAX to Report 2011 Fourth-Quarter and Year-End Financial Results on March 9, 2012

ROCKVILLE, Md., Feb. 24, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced that it will report its 2011 fourth-quarter and year-end financial results on Friday, March 9, 2012,...
February 10, 2012 10:45 ET | Source: Novavax, Inc.

NOVAVAX to Present at the 14th Annual Bio CEO & Investor Conference

ROCKVILLE, Md., Feb. 10, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company, announced today that Frederick W. Driscoll, Vice President and Chief Financial Officer...
February 01, 2012 14:53 ET | Source: Novavax, Inc.

NOVAVAX Appoints Mervyn L. Hamer, Vice President of Manufacturing

ROCKVILLE, Md., Feb. 1, 2012 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today the appointment of Mr. Mervyn L. Hamer to the position of Vice President of Manufacturing. In this role,...